Rare MYH9-ROS1 Fusion Gene-Positive Lung Adenocarcinoma Showing Response to Entrectinib Treatment: A Case Study | Citedby Results | Case Reports in Oncology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Rare MYH9-ROS1 Fusion Gene-Positive Lung Adenocarcinoma Showing Response to Entrectinib Treatment: A Case Study

Case Rep Oncol (2022) 15 (1): 376–381.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions

Yosuke Hirotsu
Takahiro Nakagomi
Yuki Nagakubo
Taichiro Goto
Masao Omata

Scientific Reports (2024) 14 (1)

A rare case of false negative ROS1 fusion in metastatic pulmonary adenocarcinoma: Case report and lessons learned

William J. Phillips
Bryan Lo
Andrea L. Gomez Corredor
Marcio M. Gomes
Paul Wheatley-Price

Clinical Lung Cancer (2023) 24 (5): e172.

FoundationOne CDx detected an uncovered variant of epidermal growth factor receptor exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma

Hiroki Takahashi
Hirokazu Ogino
Hiroki Bando
Atsushi Mitsuhashi
Yuki Tsukazaki
Yohei Yabuki
Ryohiko Ozaki
Hiroto Yoneda
Seidai Sato
Masaki Hanibuchi
Yasuhiko Nishioka

Respiratory Medicine Case Reports (2023) 45: 101893.

Antineoplastics

Reactions Weekly (2022) 1913 (1): 70.